Incelligent recombinant human insulin
Millipore (formerly Celliance) is the leading provider of recombinant human insulin for cell culture applications to the biotech industry. Millipore’s insulin products are used in more cell culture applications and in large scale industrial processes than any insulin product available. A number of key pharmaceuticals on the market today use Incelligent insulin in their manufacturing processes.
Identical in structure and function to the native human sequence. A hormone consisting of two polypeptide chains, rHu Insulin’s Achain (21 amino acids) and B-chain (30 amino acids) are covalently connected by disulfide bonds between cysteine residues. Our genetically engineered human insulin is a full sequence molecule produced by recombinant DNA technology in baker’s yeast, Saccharomyces cerevisiae. It is a white crystalline powder with a potency of = 27.5 IU/mg (dry basis).
Product News & Releases
- Millipore Introduces Solvex™ Solvent Filters - New cartridge filters ideal for sterile manufacture of APIs
- Millipore Introduces the Mobius® MIX500 Disposable Mixing System - Increased process speed and reduced risk now in a 500L size
- Millipore Expands Its NovAseptic® Mixer Family - The new GMP30000 mixer is ideal for effective mixing in large volumes
- Millipore Introduces New Service Offer for Evaluating Mixing Solutions
Featured Products
